• In early March, India’s antitrust regulator opened an investigation into International Flavors & Fragrances and other fragrance makers over alleged long‑running anti‑poaching agreements that could restrict worker mobility.
• Around the same time, International Flavors & Fragrances expanded its Health & Biosciences footprint in Latin America by converting its Arroyito, Argentina site into a full fermentation-based enzyme hub and opening a household care application lab in Brazil, signaling a push to produce and tailor enzymes locally for brewing, animal nutrition, biofuels and home care customers.
• We’ll now explore how the Indian antitrust probe, alongside Latin American enzyme expansion, reshapes International Flavors & Fragrances’ investment narrative.

Uncover the next big thing with 32 elite penny stocks that balance risk and reward.

International Flavors & Fragrances Investment Narrative Recap

To own International Flavors & Fragrances, you need to believe its shift toward higher value, innovation‑driven ingredients can turn recent losses into healthier, more durable earnings. The Indian antitrust probe adds legal and governance uncertainty to an already complex turnaround, while ongoing weakness in key markets and pressure in Fragrance Ingredients remain the main operational risks. Near term, the most important catalyst is whether recent portfolio and efficiency moves can translate into clearer progress toward profitability.

The Latin American Health & Biosciences expansion looks particularly relevant here, because it directly supports the company’s push into differentiated enzyme solutions that analysts see as central to future margin improvement. By moving from final processing to full fermentation production in Argentina and adding an application lab in Brazil, IFF is building capabilities that align with its broader focus on higher‑margin, innovation‑led growth, even as legal and competitive risks stay firmly in view.

Yet beneath the growth story, the Indian antitrust probe raises fresh questions that investors should be aware of before they decide whether...

International Flavors & Fragrances' narrative projects $11.4 billion revenue and $784.4 million earnings by 2028. This requires revenue to decline by 0.3% per year and an earnings increase of about $1.18 billion from -$393.0 million today.

Uncover how International Flavors & Fragrances' forecasts yield a $90.71 fair value, a 33% upside to its current price.

Exploring Other Perspectives

Some analysts were far more optimistic, projecting about US$11.6 billion in revenue and US$1.2 billion in earnings by 2028, but the antitrust probe and portfolio integration risk could lead you to weigh those upbeat assumptions against a very different, more cautious view.

Explore 3 other fair value estimates on International Flavors & Fragrances - why the stock might be worth as much as 73% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your International Flavors & Fragrances research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free International Flavors & Fragrances research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate International Flavors & Fragrances' overall financial health at a glance.

Want Some Alternatives?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.